In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27KIP1-inducible transcriptional program of gene expression

Journal of Cellular Physiology

Volumn 212, Issue 1, 2007, Pages 42-50

  Mayo, Clara ^a,d   Lloreta, Josep ^b,c   Real, Francisco X ^a,c   Mayol, Xavier ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA; LUCIFERASE; RNA; TRICHOSTATIN A;

ARTICLE; CANCER CELL; CELL CYCLE; CELL DIFFERENTIATION; COLON CANCER; COLON CARCINOGENESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MUCOUS CELL; MUCUS SECRETION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; WESTERN BLOTTING;

CALCIUM; CELL CYCLE; CELL DIFFERENTIATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HT29 CELLS; HUMANS; HYDROXAMIC ACIDS; INTESTINES; MUCUS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 34249884830     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20999     Document Type: Article

References (58)

1. Arsenault P, Menard D. 1989. Cell proliferation during morphogenesis of the human colon, Biol Neonate 55:137-142.
2. Baulida J, Batile Garcia De Herreros A. 1999. Adenomatous polyposis coll protein (APC)-lndependent regulation of beta-catenin/Tcf-4 mediated transcription in intestinal cells. Biochem J 344.565-570.
3. Besson A, Gurian-West M, Schmidt A, Hall A, Roberti JM. 2004. p27Klpl modulates cell migration through the regulation of RhoA activation. Genes Dev 18:862-876.
4. Chakrabany S, Radjendirane V, Appelman H, Varani J. 2003. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: Promotion of E-cadherin expression and suppression of beta-catenin/TFCF activation. Cancer Res 63:67-71.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloraform extraction. Anal Blochem 162:156-159.
6. Christofori G, Samb H. 1999. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24:73-76.
7. Deschenes C, Vezina A, Beaulieu JF, Rivard N, 2001. Role of p27(KlpI ) in human intestinal cell differentiation. Gastroenterology 120:423-438.
8. Duden R, Franke WW. 1988. Organisation of desmosomal plaque proteins in cells growing at low calcium concentrations. J Cell Biol 107:1049-1063.
9. Erickson RH, Gum JR, Lotterman CD, Hicks JW, Lai RS, Kim YS. 1999. Regulation of the gene for human dipeptidyl peptidase IV by hepatocyte nuclaar factor I alpha. Biochem J 338:91-97.
10. Fabre M, Martin M, Ullca F, Real FX. 1999. In vitro analysis of the role of DCC In mucus-secreting Intestinal differentiation. Int J Cancer 81:799-807.
11. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perimutter RM, Kaushansky K, Roberts JM. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumoriganesis, and female sterility in p27(Klp I)-deficient mice. Cell 85:733-744.
12. Gaamers IC, Vos HL, Volders HH, van der Valk SW, Hilkens J. 2001. A stat-responsive element in the promoter of the epistalin/MUC I gene is involved in its overexpression in carcinoma cells. J Biol Chem 276:6191-6199.
13. Gottardi CJ, Wong E, Gumbiner BM. 2001. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 153:1049-1060.
14. Gouyer V, Wiede A, Buisina MP, Dekeyser S, Moreau O, Lesuffleur T, Hoffmann W, Huet G. 2001. Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secrating phenotypa. Biochim Biophys Acta 1539:71-84.
15. Grana X, Garriga J, Mayol X. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365-3383.
16. Grindstaff KK, Yesman C, Anandasabapathy N, Hsu SC, Rodriguez-Boulan E, Scheller RH, Nelson WJ. 1998. Sec6/8 complex is recruited to call-cell contacts and specifies transport vesicle delivery to the basal-lateral membrane in epithelial cells. Cell 93:731-740.
17. Guaita S, Pulg I, Franci C, Garrido M, Dominguez D, Batile E, Sancho E, Dedhar S. De Herreros AG, Baulida J. 2002. 5nall Induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUCI repression and ZEBI expression. J Biol Chem 277:39209-39216.
18. Guilford P. 1999. E-cadherin downregulation in cancer Fuel on the fire? Mol Med Today 5:172-177.
19. Gumbiner B, Stevenson B, Grimaldi A. 1988. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107:1575-1587.
20. Hermiston ML, Wong MH, Gordon Jl. 1996. Forced expression of E-cadherln in the mouse Intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev 10:985-996.
21. Hershko DD, Shapira M. 2006. Prognostic role of p27Klp I deregulation in colorectal cancer. Cancer 107:668-675.
22. Hoos A, Nissan A, Stojadinovic A, Shia J, Hedvat CV, Leung DH, Paty PB, Klimstra D, Cordon-Cardo C, Wong WD. 2002. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: A comprehensive analysis. Clin Cancer Res 8:3841-3849.
23. Johnstone RW, Licht JD. 2003. Histone deacetylase inhibitors in cancer therapy. Is transcription the primary target? Cancer Cell 4:13-18.
24. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H. 1998. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking TcF-4. Nat Genet 19:379-383.
25. Kovarik A, Peat N, Wilson D, Gendler SJ, Taylor-Papadimitriou J. 1993. Analysis of the tissue-specific promoter of the MUCI gene. J Biol Chem 268:9917-9926.
26. Kovarik A, Lu PJ, Peat N, Morris J, Taytor-Papadimitriou J. 1996. Two GC boxes (SpI sites) are involved in regulation of the activity of the epithelium-specific MUCI promoter. J Biol Chem 271:18140-18147.
27. Lesuffleur T, Barbai A, Dussauix E, Zweibaum A. 1990. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50:6334-6343.
28. Lesuffleur T, Barbat A, Luccioni C, Beaumatin J, Clair M, Kornowski A, Dussauix E, Dutriliaux B. Zweibaum A. 1991. Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells. J Cell Biol 115:1409-1418.
29. Lesuffleur T, Porehet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A. 1993. Differential expression of the human mucin genes MUCI to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopuladons. J Cell Sci 106:771-783.
30. Lesuffleur T, Violette S, Vasile-Pandrea I, Dussauix E, Barbat A, Muleris M. Zweibaum A. 1998. Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype. Int J Cancer 76:383-392.
31. Leteurtre E, Gouyer V, Rousseau K, Moreau O, Barbat A, Swallow D, Huet G, Lesuffleur T. 2004. Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate. Biol Cell 96:145-151.
32. Li D, Gallup M, Fan N, Szymkowski DE, Basbaum CB. 1998. Cloning of the amino-terminal and 5′-flanking region of the human MUCSAC mucin gene and transcriptional up-regulation by bacterial exopraducts. J Biol Chem 273:6812-6820.
33. U JQ, Miki H, Wu F, Saoo K, Nishioka M, Ohmori M, lmalda K. 2002. Cyclin A correletes with carcinogenesis and metastasis, and p27(klpl) correlates with lymphatic invasion, in colorectal neoplasms. Hum Pathol 33:1006-1015.
34. Uu DF, Ferguson K, Cooper GS, Grady WM, Willis J. 1999. p27 cell-cycle inhibitor is inversely correlated with lymph node metastases in right-sided colon cancer. J Clin Lab Anal 13:291-295.
35. Marks PA, Richon VM, Miller T, Kelly WK. 2004. Histone deacetylase inhibitors. Adv Cancer Res 91:137-168.
36. Mayol X, Garriga J, Grana X. 1995, Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11:801-808.
37. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 275:1787-1790.
38. Moser AR, Pitot HC, Dove WF. 1990. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324.
39. Navarro E, Espinosa L, Adell T, Tora M, Berrozpe G, Real FX. 1999. Expressed sequence tag (EST) phenotyping of HT-29 cells: Cloning of ser/thr protein kinase EMKI, kinasin KIF3B, and of transcripts that include Alu repeated elements. Biochim Biophys Acta 1450:254-264.
40. Nelson WJ, Nusse R. 2004. Convergence of Wnt. beta-catenin, and Cadherin pathways. Science 303:1483-1487.
41. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R. 1999. E-cadherin binding prevents betacatenin nuclear localization and beta-catenin/LEF-1 -mediated transactivation. J Cell Sci 112:1237-1245.
42. Palmqvist R, Stenling R, Oberg A, Landberg G. 1999. Prognostic significance of p27(Kip I) expression in colorectal cancer: A clinico-pathological characterization. J Pathol 188:18-23.
43. Perrais M, Pigny P, Copin MC, Aubert JP, Van Sauningen I. 2002. Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp I. J Biol Chem 277:32258-32267.
44. Phllipp-Staheli J, Kim KH, Payne SR. Gurley KE, Liggite D, Langten G, Kemp CJ. 2002. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 1:355-368.
45. Prabhu S, Ignatova A, Park ST, Sun XH. 1997. Regulation of the expression of cyclin-dependent kinase inhibitor p2l by E2A and Id proteins. Mol Cell Biol 17:5888-5896.
46. Sancho E, Batile E, Clevers H. 2003. Live and let the in the intestinal epithelium. Curr Opin Cell Biol 15:763-770.
47. Savagner P. 2001. Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23:912-923.
48. Sgambato A, Ratto C, Faraglia B, Merico M, Ardito R, Schinzari G, Romano G, Cittadini AR. 1999. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Klpl) in human colon cancer. Mol Carcinog 26:172-179.
49. Sherr CJ, Roberts JM. 1999. CDK Inhibitors: Positive and negative regulators of GI-phase progression. Genet Dev 13:1501-1512.
50. St. Croix B, Sheehan C, Rak JW, Rorenes VA, Slingeriand JM, Kerbel RS. 1998. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIPI). J Cell Biol 142:557-571.
51. Stockinger A, Eger A, WoIf J, Beug H, Folsner R. 2001. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 154:1185-1196.
52. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
53. van de Watering M, Sancho E, Verweij C, da Lau W, Oving I, Huristona A, van der Horn K, Batile E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerar P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cell. Cell 111:241-250.
54. Villar-Garea A, Esteller M. 2004. Histone deacetylase inhibitors: Understanding a new wave of anticancer agents. Int J Cancer 112:171-178.
55. Wel Q, Miskimins WK, Miskimins R. 2005. Stage-specific expression of myelin basic protein in oligodendrocytes involves Nkx2.2-mediated repression that is relieved by the SpI transcription factor. J Biol Chem 280:16284-16294.
56. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J, Larsson LG. 2003. Myc represses differentiation-Induced p2ICIPI expression via Miz-1-dependent Interaction with the p2l core promoter. Oncogene 22:351-360.
57. Yang WC, Mathew J, Velcich A, Edelmann W, Kucheriapati R, Lipkin M, Yang K, Augenlicht LH. 2001. Targeted Inactivation of the p21 (WAFI/cip I) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the Intestinal mucosal. Cancer Res 61:565-569.
58. Yang W, Bancroft L, Nicholas C, Lozonschi I, Augenlicht LH. 2003. Targeted Inactivation of p27kipI is sufficient for large and small Intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet Cancer Res 63:4990-4996.